Alivus Life Sciences Limited (ALIVUS) Share Price & AI Investment Analysis

Alivus Life Sciences Limited develops and manufactures active pharmaceutical ingredients in India, the United States, Europe, Japan, Russia, Brazil, South Korea, Taiwan, Canada, China, and Australia. It offers various APIs, such as amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, solifenacin, atovaquone, etoricoxib, dapagliflozin, and sitagliptin for therapeutic areas, including cardiovascular, central nervous system, diabetes, oncology, urology, and pain management, as well as anti-fungal, anti-histaminic, anti-acne, anti-emetics immunomodulators, anti-ulceratives, immunos. Track Alivus Life Sciences Limited's live NSE:ALIVUS share price ₹1,374.20 (-1.87%), market cap ₹₹169B, P/E 28.0. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for ALIVUS — real-time NSE India stock intelligence.